HCmed Innovations Co., Ltd. (TPEX:6934)

Market Cap	4.84B
Revenue (ttm)	122.94M
Net Income (ttm)	-122.45M
Shares Out	32.72M
EPS (ttm)	-3.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	857,439
Average Volume	597,032
Open	133.50
Previous Close	133.50
Day's Range	131.00 - 150.50
52-Week Range	45.45 - 164.50
Beta	n/a
RSI	73.92
Earnings Date	Apr 10, 2026

About HCmed Innovations

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways in the United States, Europe and Asia. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services. The company...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6934

Financial Performance

In 2024, HCmed Innovations's revenue was 141.61 million, an increase of 1433.43% compared to the previous year's 9.24 million. Losses were -78.21 million, -52.86% less than in 2023.